TA

Timothy A. Springer

Professor at Harvard University

Boston, Massachusetts

Investor
VC

Invests in

Stages:

Pre-seed
Seed

Sectors:

BioTech
Health IT
Health & Hospital Services

Locations:

Massachusetts
  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Lists including Timothy A.

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AM
AT
AS
AR

All Seed Investors

19691 people

AT
AE
AE
AL

All Pre-Seed Investors

7972 people

SF
SS
ST
SJ

Pre-Seed Investors in Boston

71 people

Investments

Cartesian Therapeutics

Post Ipo Equity

Total Funding: $130M

Seismic Therapeutic

Series A

Total Funding: $220M

Selecta Biosciences

Series B

Total Funding: $150M

Prenuvo

Series A

Total Funding: $70M

Tectonic Therapeutic

Series A

Total Funding: $210M

Morphic Therapeutic

Seed

Total Funding: $140M

Scholar Rock

Series B

Total Funding: $310M

Work Experience

If
Institute for Protein Innovation

2017

  • Founder

    2017

BC
Boston Children's Hospital

2011

  • Professor Of Medicine

    2011

HM
Harvard Medical School

1989

  • Latham Family Professor

    1989

All information is sourced from public domain and might be inaccurate.

|

By continuing, you're agreeing to our Terms and Privacy Policy.

|

Learn more About The Network.